How many insider declarations has DeMuth Peter filed?

DeMuth Peter has filed 3 public insider declarations with SEC (Form 4).

What is DeMuth Peter's role?

DeMuth Peter's reported role is not specified by the regulator across the filings.

Which companies does DeMuth Peter report trades for?

DeMuth Peter reports trades for Elicio Therapeutics, Inc..

← Executives ★ Sign in to follow

DP

DeMuth Peter

OFFICER

·SEC (Form 4)

Elicio Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the complete record of transactions filed by DeMuth Peter. Insider active across 1 company, notably Elicio Therapeutics, Inc.. In total, 3 reports have been logged. History available since 16 December 2024. The latest transaction was filed on 2 February 2026 (Attribution). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to DeMuth Peter

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Elicio Therapeutics, Inc. (US)

Declarations3 total

◆

DeMuth Peter

Chief Scientific OfficerExecutives2 Feb 2026Elicio Therapeutics, Inc.

0SEC ↗

20,800 shares0Common StockSEC:0001601485-26-000006:0

◇

DeMuth Peter

Chief Scientific OfficerExecutives9 Dec 2025Elicio Therapeutics, Inc.

$1,59616SEC ↗

362 shares@ US$4.4146.2% of flowCommon StockSEC:0001601485-25-000130:0

◇

DeMuth Peter

Chief Scientific OfficerExecutives16 Dec 2024Elicio Therapeutics, Inc.

$1,68019SEC ↗

381 shares@ US$4.41100.0% of flowCommon StockSEC:0001601485-24-000109:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

DP

DeMuth Peter

OFFICER

·SEC (Form 4)

Elicio Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the complete record of transactions filed by DeMuth Peter. Insider active across 1 company, notably Elicio Therapeutics, Inc.. In total, 3 reports have been logged. History available since 16 December 2024. The latest transaction was filed on 2 February 2026 (Attribution). Regulator: SEC (Form 4). All data is free.